CDMO Archives - Page 5 of 6 - Express Pharma

Applying Agile methodologies in CDMOs

VAV Lifesciences inks deal to supply synthetic phospholipids for m-RNA based COVID-19 vaccines

Piramal Pharma to acquire 100 per cent stake in Hemmo Pharma for Rs 775 crores

Merck acquires Germany-based CDMO, AmpTec

EQT makes $2.8 bn bid for Recipharm

COVID-19 is driving more supplier redundancy

Piramal Pharma Solutions to join hands with Epirium Bio to develop and manufacture orphan drugs

Sai Life Sciences opens Research & Technology Centre in Hyderabad

Piramal collaborates with BerGenBio to develop leukemia treatment

Piramal’s Pharma business grows over 10 per cent in FY19